5-Chloro-7-methylimidazo[1,2-a]pyrimidine

Catalog No. :
ACAZJT396
CAS No. :
112266-62-3
Molecular Formula :
C7H6ClN3
Molecular Weight :
167.60

IUPAC Name:5-chloro-7-methylimidazo[1,2-a]pyrimidine

5-Chloro-7-methylimidazo[1,2-a]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$104.00Login to see priceIn stockInquiry
250mg95%$175.00Login to see priceInquiryInquiry
1g95%$488.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-7-methylimidazo[1,2-a]pyrimidine
IUPAC Name5-chloro-7-methylimidazo[1,2-a]pyrimidine
MDL No.-
Molecular FormulaC7H6ClN3
Molecular Weight167.60
SMILESCC1=NC2=NC=CN2C(Cl)=C1
InChI KeySEZYMVNWXJBYBC-UHFFFAOYSA-N
Synonym5-Chloro-7-methylimidazol[1,2-a]pyrimidine;5-Chloro-7-MethyliMidazo[1,2-a]pyriMidine;Imidazo[1,2-a]pyrimidine, 5-chloro-7-methyl-
CAS No.112266-62-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAZJT396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBPIE321 route compound structure diagram
    ACBPIE3211091729-93-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAZJT396 route product structure diagram
    ACAZJT396112266-62-3 In Stock
Inquiry

2. ACAZJT396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBPIE321 route compound structure diagram
    ACBPIE3211091729-93-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACAZJT396 route product structure diagram
    ACAZJT396112266-62-3 In Stock
Inquiry

Comments (0)